Median, 25th and 75th percentile multiples from disclosed specialty medical practice transactions, 2018-2026, by deal size (enterprise value). Cells need at least 10 deals.
| Deal size | Multiple | Median | P25 | P75 | Deals |
|---|---|---|---|---|---|
| <$5M | EV/Revenue | 1.10x | 0.35x | 2.05x | 22 |
| $5M-25M | EV/EBITDA | 5.90x | 5.10x | 8.20x | 15 |
| $5M-25M | EV/Revenue | 2.00x | 0.95x | 2.70x | 25 |
| $100M-500M | EV/EBITDA | 12.50x | 11.00x | 13.80x | 11 |
| >$500M | EV/EBITDA | 14.60x | 10.00x | 18.40x | 27 |
| >$500M | EV/Revenue | 1.60x | 1.45x | 2.40x | 17 |
Smaller deals usually trade at lower multiples than platform-sized ones, so compare a business with the row for its own size.
Specialty medical practice deal benchmarks on ExitValue.ai · How specialty medical practice businesses are valued
Estimate a specific business: free valuation calculator (full disclosure: built by the publisher of this dataset).
Open data, CC-BY-4.0. Aggregate medians of disclosed M&A transactions (licensed M&A database, SEC EDGAR filings, verified press releases). Published by ExitValue.ai · source repo · DOI 10.5281/zenodo.20398222